Analysis of Cyclin D1 in Breast Cancer: A Call to Arms

Por Tobin, Nicholas P., Bergh, Jonas
Publicado em 2012

Cyclin D1, Id1 and EMT in breast cancer

Por Tobin, Nicholas P, Sims, Andrew H, Lundgren, Katja L, Lehn, Sophie, Landberg, Göran
Publicado em 2011

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Por Milosevic, Jelena, Klinge, Johanna, Borg, Anna-Lena, Foukakis, Theodoros, Bergh, Jonas, Tobin, Nicholas P
Publicado em 2013

Stromal Expression of β-Arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer

Por Lundgren, Katja, Tobin, Nicholas P., Lehn, Sophie, Stål, Olle, Rydén, Lisa, Jirström, Karin, Landberg, Göran
Publicado em 2011

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

Por Lehn, Sophie, Tobin, Nicholas P, Sims, Andrew H, Stål, Olle, Jirström, Karin, Axelson, Håkan, Landberg, Göran
Publicado em 2014

Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features

Por Lehn, Sophie, Tobin, Nicholas P., Berglund, Pontus, Nilsson, Kristina, Sims, Andrew H., Jirström, Karin, Härkönen, Pirkko, Lamb, Rebecca, Landberg, Göran
Publicado em 2010

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

Por Paulsson, Janna, Rydén, Lisa, Strell, Carina, Frings, Oliver, Tobin, Nicholas P, Fornander, Tommy, Bergh, Jonas, Landberg, Göran, Stål, Olle, Östman, Arne
Publicado no J Pathol Clin Res (2016)

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications

Por Kimbung, Siker, Kovács, Anikó, Danielsson, Anna, Bendahl, Pär-Ola, Lövgren, Kristina, Stolt, Marianne Frostvik, Tobin, Nicholas P., Lindström, Linda, Bergh, Jonas, Einbeigi, Zakaria, Fernö, Mårten, Hatschek, Thomas, Hedenfalk, Ingrid
Publicado no Oncotarget (2015)